Clinical trial
Effect of Interferon-gamma 1-b on Innate Immune Cells
NCT02609932 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Interferon-gamma 1-b on Innate Immune Cells
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- February 28, 2019
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic granulomatous disease